Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-187X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses ; day:14 ; month:11 ; year:2019 ; pages:1-10
American journal of cardiovascular drugs ; (14.11.2019), 1-10
- Urheber
-
Shaya, Fadia Tohme
Sing, Krystal
Milam, Robert
Husain, Fasahath
Aguila, Michael A. del
Patel, Miraj Y.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40256-019-00379-9
- URN
-
urn:nbn:de:101:1-2020031218132660782273
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shaya, Fadia Tohme
- Sing, Krystal
- Milam, Robert
- Husain, Fasahath
- Aguila, Michael A. del
- Patel, Miraj Y.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
In vitro study on antioxidant and lipid-lowering activities of tobacco polysaccharides
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Nicotinic acid: a lipid-lowering agent with unrealized potential
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany